Collaborative Network Huntington Study Group operates the world’s first and largest collaborative network of over 800 experts across more than 130 credentialed research sites, presenting a robust collaboration framework for multi-site clinical trials and associated CRO partnerships.

Nonprofit Focus As a not-for-profit organization, HSG emphasizes research, education, and collaboration in Huntington’s disease, which can appeal to grant partnerships, philanthropy-driven funding opportunities, and cost-conscious sponsorships from industry stakeholders.

Clinical Operations Growth Recent leadership addition as Executive Director of Clinical Operations signals a strategic push in trial execution and operational efficiency, presenting opportunities for service expansions, onboarding of new sites, and expanded trial management collaborations.

Strategic Partnerships Past and ongoing collaborations with HD genetics firms and pharma partners (e.g., Prilenia, Neurocrine) indicate a market openness to joint studies and sponsored research, suggesting avenues for new industry partnerships and co-developed study designs.

Education and Recruitment Engine Launch of CME4HD courses and ongoing education initiatives create potential channels for sponsor-sponsored education programs, patient engagement activities, and site recruitment acceleration through accredited training collaborations.